The expression of GAGE gene can predict aggressive biologic behavior of intestinal type of stomach cancer

Hepato-Gastroenterology

Volumn 51, Issue 59, 2004, Pages 1519-1523

  Kong, UnHee ^a   Koo, JaYoung ^a   Choi, KyungHun ^a   Park, JongWook ^b   Chang, HeeKyung ^a,c  

^a Kosin University College of Medicine   (South Korea)

^b Keimyung University   (South Korea)

^c Kosin University   (South Korea)

Author keywords

Common primer; GAGE gene; Intestinal type; Stomach cancer

Indexed keywords

MESSENGER RNA; TUMOR MARKER;

ARTICLE; BEHAVIOR DISORDER; CANCER CLASSIFICATION; CANCER GENETICS; CANCER GROWTH; CANCER INVASION; CELL DIFFERENTIATION; CELL TRANSFORMATION; CONTROLLED STUDY; DISEASE MARKER; GAGE GENE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GENETIC PREDISPOSITION; GENOMIC IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; IMMUNOTHERAPY; INTESTINE; LYMPH NODE METASTASIS; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH JUICE; TISSUE DISTRIBUTION; TISSUE SECTION;

ADENOCARCINOMA; ANTIGENS, NEOPLASM; BLOTTING, SOUTHERN; GASTRECTOMY; GASTRIC JUICE; GASTRIC MUCOSA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPH NODE EXCISION; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 3342952966     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Rosenberg SA: A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity 1999; 10:281-287.
2. Yamada A, Kawano K, Harashima N, Niiya K, Kobayashi T, Mine T, Ushijama K, Nishida T, Itoh K: Study of HLA class I restriction and the directed antigens of cytotoxic T lymphocytes as the sites of ovarian cancer. Cancer Immunol Immunother 1999; 48:147-152.
3. Bruggen PV, Coulie PG, Brichard VG, Lethe B, Eynde B, Uyttenhove C, Renauld JC, Boon T: Genes coding for tumor antigens recognized cytotoxic T lymphocytes. Immunol Rev 1995; 145:229-250.
4. De Baker O, Arden KC, Boretti M, Oantomme U, De Smet C, Czekey S, Vias CS, De PlaenE, Brussen F, Chomez P, Van den Eyden B, Boon T, van der Bruggen P: Characterization of the GAGe genes that are expressed in various human cancers and in normal testis. Surg Oncol 1998; 67:126-129.
5. De Baker O, Arden KC, Boretti M, Oantomme U, De Smet C, Czekey S, Vias CS, De Plaen E, Brussen F, Chomez P, Van den Eyden B, Boon T, van der Bruggen P: Characterization of the GAGE genes that are expressed in various human cancers and in normal testis. Cancer Res 1999; 59:3157-3165.
6. Osanto S: Vaccine; Trials for the clinician; prospects for tumor antigens oncologists 1997; 2:284-299.
7. Stockert E, Jagher E, Chen YT, Scanian MJ, Gout I, Karbach J, Arnard M, Knuth A, Old LJJ A: Survey of the humoral immune response of cancer patients to a panel of human tumor antigens. Exp Med 1998; 187:1349-1354.
8. Li J, Yang Y, Fujie T, Baba K, Ueo M, Mori M, Akiyoshi T: Expression of BAGE, GAGE, and MAGE genes in human gastric carcinoma. Clin Cancer Res 1996; 2:1619-1625.
9. Zambon A, Mardruzzatis, Paouts A, Macino B, Dalerba I, Ruol A, Menigliano S, Zaninotto G, Zannello P: MAGE, BAGE, and GAGE gene expression in patients with esophageal squamous cell carcinoma and adenocarcinoma of the gastric cardia. Cancer 2001; 91:1882-1888.
10. Cheung IY, Cheng NK, Ghossei RA, Satagopan KM, Bhattachaya S, Coit DG: Association between molecular detection of GAGE and survivals in patients with malignant melanoma: a retrospective cohort study. Clin Cancer Res 1999; 5:2042-2047.
11. Van den Eynde B, Peeters O, De Backer O, Gangler B, Lucas S, Boon T: A new family of genes coding for an antigen recognized by autologous cytotoxic T lymphocytes on a human melanomas. J Exp Med 1995; 182:689-698.